Capsugel

Capsugel operates through Capsugel Healthcare Private Limited (active). Its filings, financials, charges and directors are on the company page.

Capsugel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lonza.

All

Institutional

Investor	Description	Founded Year	Domain	Location
Lonza	CDMO services for pharma, biotech, and specialty ingredients are provided.	1897	lonza.com	Basel, Switzerland

Premium access

Investor details for Capsugel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

• Complete investor list
• Round participation
• Investor portfolios
• Co-investor network

Access investors

Verified entity values are shown only after access is granted.

Capsugel Healthcare Private Limited is the primary company behind Capsugel. The board of Capsugel Healthcare Private Limited currently have 3 directors; the longest-serving is Olivier Gregory Johan Van Hoorebeke, appointed in 2016. 25 earlier directors have ceased.

5 people are tracked at Capsugel (3 in leadership, 2 in team); the tracked headcount is 244.

Figures of Capsugel Healthcare Private Limited, the primary company behind Capsugel, for FY 2025. Revenue was ₹341 Cr (+9% year on year). Net loss was -₹47.42 Cr (-14% margin). EBITDA was -₹24.20 Cr (-7% margin). Revenue has grown at a compounded annual rate of +18% over three years and +24% over five years.

• ₹341 CrRevenue · FY 2025 · +9% YoY
• -₹47.42 CrNet loss · -14% margin
• -₹24.20 CrEBITDA · -7% margin
• ₹629 CrPaid-up capital
• 244Employees (provident fund records)
• +18%Revenue CAGR, 3 years
• +24%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Capsugel Healthcare Private Limited are on its company page.

Capsugel has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Bend Research, Encap Drug Delivery and Powdersize.

6 dated milestones of Capsugel across 141 years, from founding to its latest funding, stage changes and deals.

1. 1875 Founded Capsugel is founded.
2. Mar 2013 Acquisition Acquires Encap Drug Delivery.
3. Sep 2013 Acquisition Acquires Bend Research.
4. Dec 2015 Acquisition Acquires Powdersize.
5. Dec 2015 Acquisition Acquires Xcelience.
6. Dec 2016 Exit Acquired by Lonza.

The website of Capsugel (capsugel.com) receives about 37.5K visits a month and ranks #823,274 among all websites worldwide, #983 in Biotechnology and Pharmaceuticals.

• Monthly visits
  37.5K

  ▼ 1.1% vs previous month

• Unique visitors
  17.1K

  per month

• Global rank
  #823,274

  among all websites

• Category rank
  #983

  Health · Biotechnology and Pharmaceuticals

Websites whose visitors overlap most with Capsugel. Affinity shows how closely the audiences match.

Website	Domain	Audience affinity	Monthly visits	Global rank	Profile
Torpac Capsules	torpac.com	100%		#3,734,316	View details
Catalent	catalent.com	99%	116.7K	#338,870	View details
Qualicaps	qualicaps.com	82%	1.3K	#12,645,708	View details
Intellipharmaceutics International	intellipharmaceutics.com	79%			View details
pharmasource.global	pharmasource.global	78%		#567,063	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–
••••••••••	••••••.com	••%	•.•M	#•••••	–

3 companies that operate in the same segment as Capsugel (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

Company	Description	Founded	Location	Total funding	Revenue	Employees
Indegene	Suite solutions are provided for payers and healthcare providers.	1998	Princeton, New Jersey, United States	USD 220 M	USD 374.1 M	4,490
Insulet	Wearable insulin infusion systems are developed for diabetes patients.	2000	Boston, Massachusetts, United States	USD 120.4 M	USD 2.71 B	3,900
MannKind Corp	Developer of small-molecule drugs	1991	Los Angeles, California, United States	USD 50 M	USD 348.97 M	407